Grown Rogue International (GRUSF) EBITDA Margin Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) EBITDA Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1,673.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -37.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,442.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 11,299.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3,972.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5,310.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,676.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1,106.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2,466.00 |
| 10 | Grown Rogue International | - | - | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2023 | 12,680.00 |
| Apr 30, 2023 | 11,744.00 |
| Jan 31, 2023 | 3,562.00 |
| Jan 31, 2022 | -57,136.00 |
| Jul 31, 2021 | 4,695.00 |
| Apr 30, 2021 | 15,011.00 |
| Jan 31, 2021 | 44,311.00 |
| Feb 28, 2015 | -1.44 Mn |
| Aug 31, 2014 | 461,758.00 |
| May 31, 2014 | 591,514.00 |
| Feb 28, 2014 | -437,710.00 |
| Nov 30, 2013 | 145,817.00 |
| May 31, 2013 | 127,672.00 |
| Feb 28, 2013 | -209,746.00 |
| Nov 30, 2012 | 218,843.00 |
| Aug 31, 2012 | 8.86 Mn |
| May 31, 2012 | 359,116.00 |
| Feb 29, 2012 | 2.22 Mn |